Can machine learning improve risk assessment in kidney cancer?

Current prognostic scores have moderate predictive performance, hampering the adequate selection of patients for adjuvant therapy. Explore the results of our machine learning-driven analysis of the UroCCR database – the world’s largest collaborative kidney cancer database – in our latest infographic.

First Name

Last Name

Institution

Job Title

Phone

Country

Comments

Privacy Policy I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. View our Privacy Policy for more information.

Pardot Opt-in I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time.

Comments